The global Gastric Inhibitory Polypeptide Receptor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Gastric Inhibitory Polypeptide Receptor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Gastric Inhibitory Polypeptide Receptor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Gastric Inhibitory Polypeptide Receptor include Alchemia Limited, AstraZeneca Plc, Carmot Therapeutics, Inc., Diabetica Limited, Longevity Biotech, Inc, Novo Nordisk A/S, Sanofi and Zealand Pharma A/S, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gastric Inhibitory Polypeptide Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Inhibitory Polypeptide Receptor.

Report Scope

The Gastric Inhibitory Polypeptide Receptor market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastric Inhibitory Polypeptide Receptor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastric Inhibitory Polypeptide Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastric Inhibitory Polypeptide Receptor Market Report

Report Metric	Details
Report Name	Gastric Inhibitory Polypeptide Receptor Market
Segment by Type	HM-15211 LBT-6030 LY-3298176 NNC-92041706 Others
Segment by Application	Metabolic Disorder Type 2 Diabetes Obesity Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alchemia Limited, AstraZeneca Plc, Carmot Therapeutics, Inc., Diabetica Limited, Longevity Biotech, Inc, Novo Nordisk A/S, Sanofi, Zealand Pharma A/S
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastric Inhibitory Polypeptide Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastric Inhibitory Polypeptide Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Inhibitory Polypeptide Receptor Market report?

Ans: The main players in the Gastric Inhibitory Polypeptide Receptor Market are Alchemia Limited, AstraZeneca Plc, Carmot Therapeutics, Inc., Diabetica Limited, Longevity Biotech, Inc, Novo Nordisk A/S, Sanofi, Zealand Pharma A/S

What are the Application segmentation covered in the Gastric Inhibitory Polypeptide Receptor Market report?

Ans: The Applications covered in the Gastric Inhibitory Polypeptide Receptor Market report are Metabolic Disorder, Type 2 Diabetes, Obesity, Others

What are the Type segmentation covered in the Gastric Inhibitory Polypeptide Receptor Market report?

Ans: The Types covered in the Gastric Inhibitory Polypeptide Receptor Market report are HM-15211, LBT-6030, LY-3298176, NNC-92041706, Others

1 Gastric Inhibitory Polypeptide Receptor Market Overview

1.1 Product Overview and Scope of Gastric Inhibitory Polypeptide Receptor

1.2 Gastric Inhibitory Polypeptide Receptor Segment by Type

1.2.1 Global Gastric Inhibitory Polypeptide Receptor Market Value Comparison by Type (2024-2030)

1.2.2 HM-15211

1.2.3 LBT-6030

1.2.4 LY-3298176

1.2.5 NNC-92041706

1.2.6 Others

1.3 Gastric Inhibitory Polypeptide Receptor Segment by Application

1.3.1 Global Gastric Inhibitory Polypeptide Receptor Market Value by Application: (2024-2030)

1.3.2 Metabolic Disorder

1.3.3 Type 2 Diabetes

1.3.4 Obesity

1.3.5 Others

1.4 Global Gastric Inhibitory Polypeptide Receptor Market Size Estimates and Forecasts

1.4.1 Global Gastric Inhibitory Polypeptide Receptor Revenue 2019-2030

1.4.2 Global Gastric Inhibitory Polypeptide Receptor Sales 2019-2030

1.4.3 Global Gastric Inhibitory Polypeptide Receptor Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Gastric Inhibitory Polypeptide Receptor Market Competition by Manufacturers

2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Manufacturers (2019-2024)

2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Gastric Inhibitory Polypeptide Receptor Average Price by Manufacturers (2019-2024)

2.4 Global Gastric Inhibitory Polypeptide Receptor Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Gastric Inhibitory Polypeptide Receptor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gastric Inhibitory Polypeptide Receptor, Product Type & Application

2.7 Gastric Inhibitory Polypeptide Receptor Market Competitive Situation and Trends

2.7.1 Gastric Inhibitory Polypeptide Receptor Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Gastric Inhibitory Polypeptide Receptor Players Market Share by Revenue

2.7.3 Global Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gastric Inhibitory Polypeptide Receptor Retrospective Market Scenario by Region

3.1 Global Gastric Inhibitory Polypeptide Receptor Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Gastric Inhibitory Polypeptide Receptor Global Gastric Inhibitory Polypeptide Receptor Sales by Region: 2019-2030

3.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Region: 2019-2024

3.2.2 Global Gastric Inhibitory Polypeptide Receptor Sales by Region: 2025-2030

3.3 Global Gastric Inhibitory Polypeptide Receptor Global Gastric Inhibitory Polypeptide Receptor Revenue by Region: 2019-2030

3.3.1 Global Gastric Inhibitory Polypeptide Receptor Revenue by Region: 2019-2024

3.3.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Region: 2025-2030

3.4 North America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Country

3.4.1 North America Gastric Inhibitory Polypeptide Receptor Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2030)

3.4.3 North America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Country

3.5.1 Europe Gastric Inhibitory Polypeptide Receptor Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2030)

3.5.3 Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Country

3.6.1 Asia Pacific Gastric Inhibitory Polypeptide Receptor Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2030)

3.6.3 Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Country

3.7.1 Latin America Gastric Inhibitory Polypeptide Receptor Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2030)

3.7.3 Latin America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Facts & Figures by Country

3.8.1 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2030)

3.8.3 Middle East and Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2019-2030)

4.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2019-2024)

4.1.2 Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2025-2030)

4.1.3 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2019-2030)

4.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Type (2019-2030)

4.2.1 Global Gastric Inhibitory Polypeptide Receptor Revenue by Type (2019-2024)

4.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Type (2025-2030)

4.2.3 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type (2019-2030)

4.3 Global Gastric Inhibitory Polypeptide Receptor Price by Type (2019-2030)

5 Segment by Application

5.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Application (2019-2030)

5.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Application (2019-2024)

5.1.2 Global Gastric Inhibitory Polypeptide Receptor Sales by Application (2025-2030)

5.1.3 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2019-2030)

5.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Application (2019-2030)

5.2.1 Global Gastric Inhibitory Polypeptide Receptor Revenue by Application (2019-2024)

5.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue by Application (2025-2030)

5.2.3 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application (2019-2030)

5.3 Global Gastric Inhibitory Polypeptide Receptor Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Alchemia Limited

6.1.1 Alchemia Limited Corporation Information

6.1.2 Alchemia Limited Description and Business Overview

6.1.3 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.1.5 Alchemia Limited Recent Developments/Updates

6.2 AstraZeneca Plc

6.2.1 AstraZeneca Plc Corporation Information

6.2.2 AstraZeneca Plc Description and Business Overview

6.2.3 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.2.5 AstraZeneca Plc Recent Developments/Updates

6.3 Carmot Therapeutics, Inc.

6.3.1 Carmot Therapeutics, Inc. Corporation Information

6.3.2 Carmot Therapeutics, Inc. Description and Business Overview

6.3.3 Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.3.5 Carmot Therapeutics, Inc. Recent Developments/Updates

6.4 Diabetica Limited

6.4.1 Diabetica Limited Corporation Information

6.4.2 Diabetica Limited Description and Business Overview

6.4.3 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.4.5 Diabetica Limited Recent Developments/Updates

6.5 Longevity Biotech, Inc

6.5.1 Longevity Biotech, Inc Corporation Information

6.5.2 Longevity Biotech, Inc Description and Business Overview

6.5.3 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.5.5 Longevity Biotech, Inc Recent Developments/Updates

6.6 Novo Nordisk A/S

6.6.1 Novo Nordisk A/S Corporation Information

6.6.2 Novo Nordisk A/S Description and Business Overview

6.6.3 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.6.5 Novo Nordisk A/S Recent Developments/Updates

6.7 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 Zealand Pharma A/S

6.8.1 Zealand Pharma A/S Corporation Information

6.8.2 Zealand Pharma A/S Description and Business Overview

6.8.3 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Product Portfolio

6.8.5 Zealand Pharma A/S Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Gastric Inhibitory Polypeptide Receptor Industry Chain Analysis

7.2 Gastric Inhibitory Polypeptide Receptor Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gastric Inhibitory Polypeptide Receptor Production Mode & Process

7.4 Gastric Inhibitory Polypeptide Receptor Sales and Marketing

7.4.1 Gastric Inhibitory Polypeptide Receptor Sales Channels

7.4.2 Gastric Inhibitory Polypeptide Receptor Distributors

7.5 Gastric Inhibitory Polypeptide Receptor Customers

8 Gastric Inhibitory Polypeptide Receptor Market Dynamics

8.1 Gastric Inhibitory Polypeptide Receptor Industry Trends

8.2 Gastric Inhibitory Polypeptide Receptor Market Drivers

8.3 Gastric Inhibitory Polypeptide Receptor Market Challenges

8.4 Gastric Inhibitory Polypeptide Receptor Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alchemia

Astrazeneca plc

Carmot Therapeutics, Inc.

Diabetica Limited

Longevity Biotech Inc

Novo Nordisk A S

Sanofi

Zealand Pharma A/S

List of Tables

Table 1. Global Gastric Inhibitory Polypeptide Receptor Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Gastric Inhibitory Polypeptide Receptor Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Gastric Inhibitory Polypeptide Receptor Market Competitive Situation by Manufacturers in 2023

Table 4. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Gastric Inhibitory Polypeptide Receptor Average Price (USD/Pcs) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Gastric Inhibitory Polypeptide Receptor, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Gastric Inhibitory Polypeptide Receptor, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Gastric Inhibitory Polypeptide Receptor, Product Type & Application

Table 12. Global Key Manufacturers of Gastric Inhibitory Polypeptide Receptor, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Gastric Inhibitory Polypeptide Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Inhibitory Polypeptide Receptor as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastric Inhibitory Polypeptide Receptor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Gastric Inhibitory Polypeptide Receptor Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2019-2024)

Table 19. Global Gastric Inhibitory Polypeptide Receptor Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2025-2030)

Table 21. Global Gastric Inhibitory Polypeptide Receptor Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2019-2024)

Table 23. Global Gastric Inhibitory Polypeptide Receptor Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2025-2030)

Table 25. North America Gastric Inhibitory Polypeptide Receptor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Gastric Inhibitory Polypeptide Receptor Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Gastric Inhibitory Polypeptide Receptor Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Gastric Inhibitory Polypeptide Receptor Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gastric Inhibitory Polypeptide Receptor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Gastric Inhibitory Polypeptide Receptor Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Gastric Inhibitory Polypeptide Receptor Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Type (2019-2024)

Table 51. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Type (2025-2030)

Table 52. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2019-2024)

Table 53. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2025-2030)

Table 54. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type (2019-2024)

Table 57. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type (2025-2030)

Table 58. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Type (2019-2024)

Table 59. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Type (2025-2030)

Table 60. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Application (2019-2024)

Table 61. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Application (2025-2030)

Table 62. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2019-2024)

Table 63. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2025-2030)

Table 64. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application (2019-2024)

Table 67. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application (2025-2030)

Table 68. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Application (2019-2024)

Table 69. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Application (2025-2030)

Table 70. Alchemia Limited Corporation Information

Table 71. Alchemia Limited Description and Business Overview

Table 72. Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 73. Alchemia Limited Gastric Inhibitory Polypeptide Receptor Product

Table 74. Alchemia Limited Recent Developments/Updates

Table 75. AstraZeneca Plc Corporation Information

Table 76. AstraZeneca Plc Description and Business Overview

Table 77. AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 78. AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Product

Table 79. AstraZeneca Plc Recent Developments/Updates

Table 80. Carmot Therapeutics, Inc. Corporation Information

Table 81. Carmot Therapeutics, Inc. Description and Business Overview

Table 82. Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 83. Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Product

Table 84. Carmot Therapeutics, Inc. Recent Developments/Updates

Table 85. Diabetica Limited Corporation Information

Table 86. Diabetica Limited Description and Business Overview

Table 87. Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 88. Diabetica Limited Gastric Inhibitory Polypeptide Receptor Product

Table 89. Diabetica Limited Recent Developments/Updates

Table 90. Longevity Biotech, Inc Corporation Information

Table 91. Longevity Biotech, Inc Description and Business Overview

Table 92. Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 93. Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Product

Table 94. Longevity Biotech, Inc Recent Developments/Updates

Table 95. Novo Nordisk A/S Corporation Information

Table 96. Novo Nordisk A/S Description and Business Overview

Table 97. Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 98. Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Product

Table 99. Novo Nordisk A/S Recent Developments/Updates

Table 100. Sanofi Corporation Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 103. Sanofi Gastric Inhibitory Polypeptide Receptor Product

Table 104. Sanofi Recent Developments/Updates

Table 105. Zealand Pharma A/S Corporation Information

Table 106. Zealand Pharma A/S Description and Business Overview

Table 107. Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 108. Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Product

Table 109. Zealand Pharma A/S Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Gastric Inhibitory Polypeptide Receptor Distributors List

Table 113. Gastric Inhibitory Polypeptide Receptor Customers List

Table 114. Gastric Inhibitory Polypeptide Receptor Market Trends

Table 115. Gastric Inhibitory Polypeptide Receptor Market Drivers

Table 116. Gastric Inhibitory Polypeptide Receptor Market Challenges

Table 117. Gastric Inhibitory Polypeptide Receptor Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Gastric Inhibitory Polypeptide Receptor

Figure 2. Global Gastric Inhibitory Polypeptide Receptor Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Gastric Inhibitory Polypeptide Receptor Market Share by Type in 2023 & 2030

Figure 4. HM-15211 Product Picture

Figure 5. LBT-6030 Product Picture

Figure 6. LY-3298176 Product Picture

Figure 7. NNC-92041706 Product Picture

Figure 8. Others Product Picture

Figure 9. Global Gastric Inhibitory Polypeptide Receptor Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Gastric Inhibitory Polypeptide Receptor Market Share by Application in 2023 & 2030

Figure 11. Metabolic Disorder

Figure 12. Type 2 Diabetes

Figure 13. Obesity

Figure 14. Others

Figure 15. Global Gastric Inhibitory Polypeptide Receptor Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Gastric Inhibitory Polypeptide Receptor Market Size (2019-2030) & (US$ Million)

Figure 17. Global Gastric Inhibitory Polypeptide Receptor Sales (2019-2030) & (K Pcs)

Figure 18. Global Gastric Inhibitory Polypeptide Receptor Average Price (USD/Pcs) & (2019-2030)

Figure 19. Gastric Inhibitory Polypeptide Receptor Report Years Considered

Figure 20. Gastric Inhibitory Polypeptide Receptor Sales Share by Manufacturers in 2023

Figure 21. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Gastric Inhibitory Polypeptide Receptor Players: Market Share by Revenue in 2023

Figure 23. Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Gastric Inhibitory Polypeptide Receptor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2019-2030)

Figure 26. North America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2019-2030)

Figure 30. Europe Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2019-2030)

Figure 31. Germany Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2019-2030)

Figure 38. China Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2019-2030)

Figure 49. Latin America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. UAE Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Gastric Inhibitory Polypeptide Receptor by Type (2019-2030)

Figure 59. Global Revenue Market Share of Gastric Inhibitory Polypeptide Receptor by Type (2019-2030)

Figure 60. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Type (2019-2030)

Figure 61. Global Sales Market Share of Gastric Inhibitory Polypeptide Receptor by Application (2019-2030)

Figure 62. Global Revenue Market Share of Gastric Inhibitory Polypeptide Receptor by Application (2019-2030)

Figure 63. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Application (2019-2030)

Figure 64. Gastric Inhibitory Polypeptide Receptor Value Chain

Figure 65. Gastric Inhibitory Polypeptide Receptor Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastric Mucosal Protective Agent Market Research Report 2025

Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Research Report 2024

Global CGRP Receptor Antagonists Market Research Report 2024

Global Gastric Antisecretory Drug Market Insights Forecast to 2030

Global SGLT2 Inhibitors Market Research Report 2025

Global Stomach Acid Suppressing Drug Market Research Report 2024

Global Gastric Helicobacter Pylori Detection Kits Market Research Report 2024

B Cell Receptor Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GCG Receptor Agonist Market Research Report 2024

Global Gastric Ulcer Detection Kits Market Research Report 2024

Global Gastrin Hormone Market Research Report 2025

G protein Coupled Receptor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Testing Panel Market Research Report 2024

Global Antiulcer Agents and Acid Suppressants Market Research Report 2024

Global Polypeptide API Market Research Report 2024

Global Nociceptin Receptor Market Research Report 2024

Global SGLT2 Inhibitor Market Insights Forecast to 2030

Global B Cell Inhibitor Market Research Report 2025

EGFR Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Gastric Mucosal Protective Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26U19007

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Anesthetic Gas Purification and Recovery Device Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37Q15545

Fri May 16 00:00:00 UTC 2025

Add to Cart

Global Beating Heart Stabilizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2R15767

Fri May 16 00:00:00 UTC 2025

Add to Cart

Global Bipolar Disorder Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Z15903

Fri May 16 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions